# OnCo record kara-kelly (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/kara-kelly/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "kara-kelly" ;
  schema:name "Kara M. Kelly"@en ;
  schema:description "Leads the COG Hodgkin lymphoma committee and the trials bringing brentuximab and nivolumab to children with the disease."@en ;
  schema:url <https://onco.cc/people/kara-kelly/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Kelly%20KM%5BAuthor%5D%20Hodgkin%20children> ;
  onco:tag "paediatric", "hodgkin", "cooperative-group" ;
  schema:jobTitle "Chair of Pediatric Oncology, Roswell Park Comprehensive Cancer Center; Division Chief, Pediatric Hematology/Oncology, University at Buffalo" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:institutions <https://onco.cc/institutions/roswell-park/> ;
  onco:trials <https://onco.cc/trials/ahod2131/>, <https://onco.cc/trials/swog-s1826/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-swog-s1826-nivolumab-avd-nejm-2024/> ;
  schema:affiliation <https://onco.cc/institutions/roswell-park/> .
